Home › Funds › Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. › CYTK
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. position in CYTK
CYTOKINETICS INC · Health Care
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. reported holding 660,310 shares of CYTK (CYTOKINETICS INC) in its Q3 2026 13F filing — a position valued at US$43.5M, representing 2.09% of its reported portfolio and ranking #20 among its reported holdings. Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. has disclosed CYTK holdings in 10 of the last 12 reported quarters, going back to Q4 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A.'s CYTK position evolved
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. first disclosed a stake in CYTK in Q4 2023 at 344,484 shares (US$28.8M). The position peaked in Q3 2025 at 1,192,484 shares, worth US$65.5M. Across 10 filings, Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. increased the stake 3 time(s), trimmed it 3 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 660,310 shares valued at US$43.5M. Notable position changes include a 51% trim in Q1 2025 (shares fell 18% over the following quarter), a 571% increase in Q2 2025 (shares rose 66% over the following quarter), a 37% trim in Q4 2025 (shares rose 4% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 344.48K | $28.76M | New |
| Q1 2024 | 461.02K | $32.32M | Add |
| Q4 2024 | 329.14K | $15.48M | New |
| Q1 2025 | 161.28K | $6.48M | Reduce |
| Q2 2025 | 1.08M | $35.77M | Add |
| Q3 2025 | 1.19M | $65.54M | Add |
| Q4 2025 | 747.98K | $47.53M | Reduce |
| Q1 2026 | 660.31K | $43.52M | Reduce |
| Q2 2026 | 660.31K | $56.25M | Hold |
| Q3 2026 | 660.31K | $43.52M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CYTK and 13F data
CYTK (CYTOKINETICS INC) is a Health Care company. 44 other funds we track also report a position in CYTK — the largest reported positions include T. Rowe Price Investment Management, Inc. (US$1.59B), Avoro Capital Advisors LLC (US$425.9M), RTW INVESTMENTS, LP (US$243.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CYTK
- T. Rowe Price Investment Management, Inc. 18.72M sh · $1.59B · Q2 2026
- Avoro Capital Advisors LLC 5.00M sh · $425.95M · Q2 2026
- RTW INVESTMENTS, LP 2.86M sh · $243.81M · Q2 2026
- Polar Capital Holdings Plc 2.25M sh · $191.99M · Q2 2026
- Integral Health Asset Management, LLC 1.60M sh · $136.30M · Q2 2026
- ARMISTICE CAPITAL, LLC 1.20M sh · $102.34M · Q2 2026
- Frazier Life Sciences Management, L.P. 1.16M sh · $98.81M · Q2 2026
- Royalty Pharma Sub-Manager, LLC 980.39K sh · $83.52M · Q2 2026
- GW&K Investment Management, LLC 1.02M sh · $67.08M · Q3 2026
- Melqart Asset Management (UK) Ltd 767.52K sh · $65.39M · Q2 2026
- Foresite Capital Management IV, LLC 714.70K sh · $60.88M · Q2 2026
- Deep Track Capital, LP 700.00K sh · $59.63M · Q2 2026
More on Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A.
FAQ
How long has Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. held CYTK?
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. has disclosed CYTK holdings in 10 of the last 12 reported quarters, going back to Q4 2023.
What is Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A.'s current position in CYTK?
As of Q3 2026, Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. holds 660.31K shares of CYTK (CYTOKINETICS INC), valued at $43.52M, representing 2.09% of its reported portfolio and ranking #20.
Has Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. been buying or selling CYTK?
In the latest 13F filing (Q3 2026), Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. held unchanged its position in CYTK. The position peaked in Q3 2025 at 1.19M shares.
Which other funds hold CYTK?
Other major institutional holders of CYTK include T. Rowe Price Investment Management, Inc., Avoro Capital Advisors LLC, RTW INVESTMENTS, LP, among 44 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.